Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Farde

Showing results (181-190 of 218) with videos related to

Pageof 22
Sort By:
Biological Psychiatry|April 8, 2003
Association between a promoter dopamine D2 receptor gene variant and the personality trait detachmentErik G Jönsson, Sven Cichon, J Petter Gustavsson, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [<sup>11</sup>C]AZD2423Kenneth Dahl, Peter Johnström, Miklós Tóth, et al.
Biological Psychiatry|June 9, 2009
Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in menSusanne Henningsson, Jacqueline Borg, Johan Lundberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
The International Journal of Neuropsychopharmacology|January 8, 2009
Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humansJacqueline Borg, Susanne Henningsson, Tomoyuki Saijo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 23, 2019
A PET study in healthy subjects of brain exposure of <sup>11</sup>C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancerAndrea Varrone, Katarina Varnäs, Aurelija Jucaite, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humansZsolt Cselényi, Aurelija Jucaite, Pär Ewing, et al.
The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.
Molecular Imaging and Biology|March 17, 2004
The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivoJulie A McCarron, Victor W Pike, Christer Halldin, et al.
The International Journal of Neuropsychopharmacology|March 20, 2016
Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628Katarina Varnäs, Sjoerd J Finnema, Vladimir Stepanov, et al.
Pageof 22

Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Biological Psychiatry|April 8, 2003
Association between a promoter dopamine D2 receptor gene variant and the personality trait detachmentErik G Jönsson, Sven Cichon, J Petter Gustavsson, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [<sup>11</sup>C]AZD2423Kenneth Dahl, Peter Johnström, Miklós Tóth, et al.
Biological Psychiatry|June 9, 2009
Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in menSusanne Henningsson, Jacqueline Borg, Johan Lundberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2016
Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainKai-Chun Yang, Vladimir Stepanov, Nahid Amini, et al.
The International Journal of Neuropsychopharmacology|January 8, 2009
Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humansJacqueline Borg, Susanne Henningsson, Tomoyuki Saijo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 23, 2019
A PET study in healthy subjects of brain exposure of <sup>11</sup>C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancerAndrea Varrone, Katarina Varnäs, Aurelija Jucaite, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humansZsolt Cselényi, Aurelija Jucaite, Pär Ewing, et al.
The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.
Molecular Imaging and Biology|March 17, 2004
The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivoJulie A McCarron, Victor W Pike, Christer Halldin, et al.
The International Journal of Neuropsychopharmacology|March 20, 2016
Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628Katarina Varnäs, Sjoerd J Finnema, Vladimir Stepanov, et al.
Pageof 22